Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: A meta-analysis

The 17-gene Genomic Prostate Score (GPS) test has been clinically employed to predict adverse prognosis in prostate cancer. In this meta-analysis, we aimed to evaluate the prognostic value of the 17-gene GPS in patients with prostate cancer